Skip to main content
Orthopaedic Journal of Sports Medicine logoLink to Orthopaedic Journal of Sports Medicine
. 2019 Aug 19;7(8):2325967119862750. doi: 10.1177/2325967119862750

Cardiovascular Health of Retired Field-Based Athletes: A Systematic Review and Meta-analysis

Cliodhna McHugh †,*, Karen Hind , Daniel Davey §, Fiona Wilson
PMCID: PMC6700959  PMID: 31457065

Abstract

Background:

Retirement from elite sport participation is associated with decreased physical activity, depression, obesity, and ischemic heart disease. Although engagement in physical activity through sport is recognized as cardioprotective, an estimated one-quarter of deaths in American football players are associated with cardiovascular disease (CVD), predominately in players classified as obese.

Purpose:

To systematically investigate the cardiovascular health profile of retired field-based athletes.

Study Design:

Systematic review; Level of evidence, 4.

Methods:

This review was conducted and reported in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and preregistered with PROSPERO. Four databases (PubMed, CINAHL, Embase, and Web of Science) were systematically searched from inception to October 2018 using MeSH terms and keywords. Inclusion criteria were retired field-based athletes, age >18 years, and at least 1 CVD risk factor according to the European Society of Cardiology and the American Heart Association. Review articles were not included. Control groups were not required for inclusion, but when available, an analysis was included. Eligible articles were extracted using Covidence. Methodological quality was assessed independently by 2 reviewers using the AXIS tool. The accuracy of individual study estimates was analyzed using a random-effects meta-analysis.

Results:

This review yielded 13 studies. A total of 4350 male retired field-based athletes from 2 sports (football and soccer; age range, 42.2-66 years) were included. Eight studies compared retired athletes with control groups. Retired athletes had elevated systolic blood pressure in 4 of 6 studies; approximately 50% of studies found greater high-density lipoprotein, approximately 80% found lower triglyceride levels, and all studies found greater low-density lipoprotein for retired athletes compared with controls. The prevalence and severity of coronary artery calcium and carotid artery plaque were similar to controls. Retired linemen had double the prevalence of cardiometabolic syndrome compared with nonlinemen.

Conclusion:

The overall findings were mixed. Inconsistencies in the reporting of CVD risk factors and methodological biases reduced the study quality. Retired athletes had a comparable CVD risk profile with the general population. Retired athletes with an elevated body mass index had an increased prevalence and severity of risk factors. Significant gaps remain in understanding the long-term cardiovascular effects of elite athleticism.

Keywords: cardiovascular, heart disease, retired athletes, field-based, evidence-based review, risk factors


Regular physical activity is recommended for the optimization of cardiovascular health and the reduction of all-cause mortality, whereas obesity is an established risk factor for cardiovascular disease (CVD).12,25,65,71 Field-based athletes from sports such as American football and rugby present with a greater body mass index (BMI) along with superior aerobic fitness.11,25,43,60,68,75 However, the cardiovascular health of these athletes after retirement is unclear. Premature mortality from CVD has become a prominent topic of discussion for field-based athletes, particularly during the transition into retirement.3 Athletes are typically perceived as a healthy cohort, with evidence to support that fitness provides protection against known health risks of obesity12,36 and relevant comorbidities.54,59 Research also demonstrates that although exercise has beneficial cardioprotective qualities, it does not necessarily translate into immunity from cardiovascular risk.28 An estimated one-quarter of football players’ deaths are associated with CVD, predominately in those classified as obese.24 Furthermore, when compared with retired baseball players, retired football players are more than twice as likely to die before the age of 50 years.24 A study from the US National Institute for Occupational Safety and Health (NIOSH) found that although overall mortality from CVD in retired football players was 46% lower than in the general population, linemen had a 52% greater risk.3 It has been suggested that this may, in part, reflect increased cardiovascular risk factors associated with a greater body size.3,26 The BMI of football players often falls into the obesity range.11,25,42,68,75 However, the applicability of BMI in this cohort is widely criticized because of the players' high muscle mass, leading to an overestimation of body fat percentage.48,49,50,62 However, it is unknown if BMI remains inapplicable following retirement from elite athleticism.

To our knowledge, there has been no published review on the evidence concerning cardiovascular health in retired field-based athletes. The long-term cardiovascular health risks for professional athletes remain largely unclear. Therefore, the primary purpose of this review was to systematically collate and appraise the evidence on the cardiovascular health and the prevalence of CVD risk factors in retired field-based athletes. Furthermore, this review aimed to investigate the prevalence of factors that influence mortality from CVD, including obesity,29,32 hypertension,40 dyslipidemia,58 glucose intolerance,17 cardiometabolic syndrome (CMS),17 coronary artery calcium (CAC),61,67 and sleep-disordered breathing (SDB).56,66

Methods

This review was conducted and reported in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement (www.prisma-statement.org)45 and was registered with PROSPERO, a registry of systematic reviews https://www.crd.york.ac.uk/prospero; registration No. CRD42017077885). Articles were retrieved via online database search engines including CINAHL, Embase, PubMed, and Web of Science. The reference lists of all reviews related to cardiovascular health and articles meeting the eligibility criteria were reviewed manually for suitability.

Keywords and MeSH terms were searched alone and in combination. The following keywords were included: CVD, cardiovascular health, blood pressure, lipids, cholesterol, cardio-metabolic syndrome, hypertension, glucose intolerance, body composition, body mass index, body fat percentage, low-density lipoprotein, high-density lipoprotein, triglycerides, total cholesterol, sleep-disordered breathing, field-based athlete, American football, baseball, field hockey, rugby, Gaelic football, and soccer. The inclusion criteria consisted of retired athletes from a field-based sport older than 18 years and studies that investigated at least 1 known risk factor for CVD according to the European Society of Cardiology (ESC)54 and American Heart Association (AHA).72 The search was not limited by language or publication status, and no date restriction was implemented. Articles were excluded if the study design was a review paper and if retired athletes with a prior cardiovascular event were included. The inclusion of controls was not required.

A 3-step screening strategy was implemented to identify appropriate relevant articles using Covidence (www.covidence.org) (Figure 1). Titles and abstracts were screened by 2 authors (C.M., F.W.) blinded to each other’s selection, in accordance with the aforementioned inclusion criteria. Then, reviewers independently screened full texts (Appendix Table A1). A third reviewer (K.H.) was consulted to make a final decision when a consensus was not reached between the 2 reviewers. Manual searches were performed of reference lists of the selected articles. The search methodology and process are described in Figure 1. Eligible articles were critically appraised, and quality was assessed with full-text screening using the AXIS tool for the critical appraisal of cross-sectional studies (Table 1).14 When studies were agreed upon, 1 reviewer extracted data from selected studies to create an evidence table using STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.70

Figure 1.

Figure 1.

PRISMA (Preferred Reporting Items for Systematic Meta-Analyses) flow diagram. BMI, body mass index; CVD, cardiovascular disease; ECG, electrocardiogram; ECHO, echocardiography; GAA, Gaelic Athletic Association; NFL, National Football League.

TABLE 1.

Critical Appraisal of Included Studiesa

Miller et al44 (2008) Panayiotoglou et al52 (2017) Basra et al4 (2014) Chang et al9 (2009) Hurst et al30 (2010) Hyman et al31 (2012) Albuquerque et al1 (2010) Carruthers et al7 (2017) Kelly et al34 (2014) Lynch et al39 (2007) Pokharel et al55 (2014) Virani et al69 (2012) Luyster et al38 (2017)
Introduction
Were the aims/objectives of the study clear? N Y Y Y U Y N N Y N Y Y Y
Methods
Was the study design appropriate for the stated aim(s)? Y Y Y Y Y Y Y Y Y Y Y Y Y
Was the sample size justified? N N Y Y N N Y N N N N N Y
Was the target reference population clearly defined? Y Y Y Y Y N Y Y Y Y Y Y Y
Was the sample taken from an appropriate population base so that it closely represented the target/reference population under investigation? Y Y Y Y Y N Y U Y Y Y Y Y
Was the selection process likely to select participants who were representative of the target/reference population under investigation? Y Y Y Y Y Y U U Y Y Y Y Y
Were there measures undertaken to address and categorize nonresponders? N N N N N N U N Y N U U N
Were the risk factor and outcome variables measured appropriately to the aims of the study? Y Y Y Y Y Y Y Y Y Y Y Y Y
Were the risk factor and outcome variables measured correctly using instruments/measurements that had been trialed, piloted, or published previously? Y Y Y Y Y U Y U Y Y Y Y Y
Is it clear what was used to determine statistical significance and/or precision estimates (eg, values, CIs)? Y Y Y Y Y N N N Y Y Y Y Y
Were the methods (including statistical methods) sufficiently described to enable them to be repeated? Y Y Y Y Y N N N Y Y Y Y Y
Results
Were the basic data adequately described? Y Y Y Y Y Y N Y Y Y Y Y Y
Does the response rate raise concern about nonresponse bias? Y Y N N Y Y Y U N Y Y N N
If appropriate, was information about nonresponders described? N N N U U N N U U N U U N
Were the results internally consistent? Y Y Y Y Y Y U Y Y Y Y Y Y
Were the results for the analyses described in the methods presented? Y Y Y Y Y Y N Y Y Y Y Y Y
Discussion
Were the authors’ discussions and conclusions justified by the results? Y Y Y Y Y Y Y Y Y Y Y Y Y
Were the limitations of the study discussed? Y Y Y Y Y Y N Y Y Y Y Y Y
Other
Were there any funding sources or conflicts of interest that may affect the authors’ interpretation of the results? N Y N N N N N N N N N N N
Was ethical approval or consent of participants attained? Y Y Y Y Y Y U Y Y Y Y Y Y

aColored text indicates the following: green, positive impact on quality of study; red, negative impact on quality of study; orange, unknown impact on quality of study. N, no; U, unsure; Y, yes.

We assessed the precision and accuracy of individual study estimates by conducting a random-effects meta-analysis to examine the overall effect. Heterogeneity between studies was determined by the I2 statistic27 as an indicator of the proportion of the total variation in estimates that is caused by heterogeneity. I2 values of 25%, 50%, and 75% correspond to low, moderate, and high degrees of heterogeneity, respectively. Where high levels of heterogeneity were detected (I2 > 75%), a sensitivity analysis was conducted. Findings from the random-effects meta-analysis are represented through forest plots. Studies removed during the sensitivity analysis are represented by 0.0% weight in forest plot figures.

Results

Overall, 1816 articles (after the removal of 12 duplicates from the original 1828 articles) were retrieved. After screening the titles and abstracts based on our inclusion criteria, 1583 articles were excluded. This left 233 articles for full-text screening, from which 76 were excluded because study participants were current athletes, 132 were excluded because of the studies’ primary outcomes not being relevant to a traditional cardiovascular health assessment, 10 were excluded because of the study design and insufficient data presented, and 2 were excluded because of no access to the full text. Overall, 13 studies were identified as relevant to cardiovascular health from 2 field-based sports (football and soccer).

Of the 13 relevant studies, 11 were cross-sectional, 1 observational, and 1 prospective in the study design. All participants were male and retired professional football (12/13) or professional soccer (1/13) players.52 Twelve studies were conducted in the United States and 1 in Greece52 (Appendix Table A1). The included studies consisted of large (n = 948 athletes) and small (n = 12 athletes) cohorts. Studies compared athletes with age- and sex-matched controls, mainly derived from subsets of the following population cohorts: the National Health and Nutrition Examination Survey (longitudinal data collected in 1999-2006), the Coronary Artery Risk Development in Young Adults (CARDIA; study of cardiovascular risk development in young adults [n = 5116]), the Mayo Clinic (database of all patients who underwent a cardiovascular risk evaluation in 2006-2008), the Dallas Heart Study (DHS; probability-based cohort of Dallas County adults, oversampled for African Americans [n = 6101]), and the Aerobics Center Longitudinal Study (ACLS; longitudinal study of medical health). Participants were selected from a subset of 5322 of a total 17,967 participants (Appendix Table A1).

An analysis was carried out to assess CVD risk factors according to the ESC and AHA guidelines to compare risk factors based on sport and playing position with control groups. The included studies evaluated cardiovascular health and the CVD risk in retired athletes under the following categories: body composition (BMI, body fat percentage, waist circumference, neck circumference, waist-to-hip ratio), blood pressure (BP), lipids (total cholesterol, high-density lipoprotein [HDL], low-density lipoprotein [LDL], triglycerides, total cholesterol/HDL ratio, triglyceride/HDL ratio), glucose, CMS,23 CAC/carotid artery plaque (CAP),22 and SDB.64

Body Composition

Eleven studies assessed BMI,** accounting for 3273 retired athletes (10 football, 1 soccer) with a mean BMI of 29.5 kg/m2 (football: 31.7 kg/m2; soccer: 27.3 kg/m2). Football players had a greater mean BMI than controls.1,7,9,38 Compared with controls, retired athletes had lower body fat percentages.39,52 A lower waist circumference was reported for retired athletes compared with the DHS cohort, the CARDIA cohort, and a control group.9,38,39 However, compared with the ACLS cohort, retired football players had a higher mean waist circumference (Table 2).9 Conflicting waist-to-hip ratio findings were reported for retired football athletes.9,39 The waist-to-hip ratio was found to be considerably lower for retired soccer players than for football players. Using BMI ≥30 kg/m2, 67% of retired players were classified as obese compared with 10% when classifying body fat percentage ≥25% via dual-energy x-ray absorptiometry (DXA).31

TABLE 2.

Body Composition Measuresa

Author (Year) BMI, kg/m2 WC/NC, cm BF% WHR
Miller et al44 (2008) LM vs NLM: 34.9 (4.9) vs 30.7 (4.0)b LM vs NLM: 31.4% vs 27.4%b
BF% >28%: LM vs NLM: 111 (67.7%) vs 145 (41.9%)b
Panayiotoglou et al52 (2017) Soccer vs control: 27.3 ± 2.8 vs 27.4 ± 2.7, NS Soccer vs control: 24.5 ± 4.5 vs 27.0 ± 3.9, NS Soccer vs control: 0.96 ± 0.05 vs 0.97 ± 0.01, NS
Basra et al4 (2014) LM vs NLM: 33.6 (30.5-37.9) vs 30.3 (27.7-33.0)b LM vs NLM: 109.2 (99.1-119.4) vs 99.1 (91.4-106.6)b
Chang et al9 (2009) NFL vs DHS: 31.5 ± 4.2 vs 31.4 ± 4.0, NS
NFL vs ACLS: 31.7 ± 4.7 vs 28.6 ± 3.1b
NFL vs DHS: 103.8 ± 11.5 vs 107.4 ± 10.9, NS
NFL vs ACLS: 105.7 ± 12.7 vs 98.4 ± 8.9b
NFL vs DHS: 1.08 ± 0.85 vs 0.98 ± 0.05b
NFL vs ACLS: 1.06 ± 0.73 vs 0.93 ± 0.05b
Hurst et al30 (2010) NFL vs Mayo: 31.5 ± 4.5 vs 31.0 ± 2.7, NS
LM vs NLM: 34.2 ± 4.5 vs 30.5 ± 4.0b
Hyman et al31 (2012) BMI ≥30 = 89 (67%)
BMI correlated with LMb
BF% ≥25% = 13 (10%)
Albuquerque et al1 (2010) NFL vs control: 32.3 ± 0.3 vs 30.0 ± 0.1b
Carruthers et al7 (2017) NFL vs DHS: 32.5 (5.4) vs 29.3 (5.4)b
Kelly et al34 (2014) 33.8 ± 6
BMI = 30: 45 (66.2%)
Lynch et al39 (2007) NFL vs control: 29.4 ± 2.8 vs 30 ± 3, NS NFL vs control: 101.2 ± 6.8 vs 106.1 ± 8.0, NS NFL vs control: 23 ± 4 vs 32 ± 7b NFL vs control: 0.95 ± 0.05 vs 0.98 ± 0.06, NS
Pokharel et al55 (2014) 31 (29-35) WC: 40 (37-44)
NC: 17 (16-18)
Virani et al69 (2012) WC: 39.4 ± 10.6
Luyster et al38 (2017) NFL vs CARDIA: 30.3 ± 3.8 vs 29.9 ± 4.0, NS
LM vs NLM: 29.8 ± 2.9 vs 30.5 ± 4.1, NS
BMI ≥30: NFL vs CARDIA: 60 (49.2%) vs 51 (41.8%), NS
BMI ≥30: LM vs NLM: 13 (38.2%) vs 47 (53.4%), NS
NFL vs CARDIA: 95.2 ± 22.0 vs 98.1 ± 10.2, NS
LM vs NLM: 92.6 ± 19.7 vs 96.2 ± 22.8, NS

aData are reported as mean ± SD, median (interquartile range), or n (%). ACLS, Aerobics Center Longitudinal Study; BF%, body fat percentage; BMI, body mass index; CARDIA, Coronary Artery Risk Development in Young Adults; DHS, Dallas Heart Study; LM, linemen; Mayo, Mayo Clinic; NC, neck circumference; NFL, National Football League; NLM, nonlinemen; NS, not significant; WC, waist circumference; WHR, waist-to-hip ratio.

bP < .001.

A subgroup analysis found that retired linemen had elevated measures of body composition compared with retired nonlinemen: a higher BMI4,30,38,44 and higher body fat percentages.44 Conflicting findings were reported on the waist circumference between retired linemen and retired nonlinemen.4,38

Hypertension and Blood Pressure

A greater incidence of hypertension was reported in retired athletes compared with controls.1,4,30,38 Retired linemen had a higher prevalence of hypertension compared with retired nonlinemen, although not significantly (Table 3).4,30,38,44 Most studies found higher resting systolic BP in retired football players compared with controls (Table 3).1,7,9,30,38,39 Conflicting findings were reported for the subgroup analysis in football players (Table 3).4,30,38,44

TABLE 3.

Risk Factors for Cardiovascular Diseasea

Author (Year) Blood Pressure Lipids, mg/dL CAC CMS
Miller et al44 (2008) LM vs NLM:
HT: 41 (25%) vs 71 (20.5%), NS
SBP: 137.1 (21.3) vs 131.9 (17.4)b
DBP: 79.2 (13.3) vs 78.5 (11.4), NS
LM vs NLM:
HDL: 44.5 (14.2) vs 47.6 (14.9)c
TC: 189.1 (43.9) vs 195.6 (38.6), NS
TG: 128.5 (79.8) vs 116.1 (70.8), NS
LM vs NLM: 98 (59.8%) vs 104 (30.1%)d
BMI ≥30: 140 (85.4%) vs 174 (50.3%)d
Raised blood pressure: 111 (67.7%) vs 212 (61.3%), NS
Reduced HDL: 69 (42.1%) vs 113 (32.7%), NS
Raised fasting glucose: 99 (60.4%) vs 130 (37.6%)d
Raised TG: 51 (31.1%) vs 83 (24.0%), NS
Panayiotoglou et al52 (2017) Soccer vs control:
TG (mM): 1.1 ± 0.2 vs 1.6 ± 0.8, NS
Basra et al4 (2014) LM vs NLM:
HT: 38.8% vs 28.5%b
SBP: 131 (122-144) vs 130 (120-143), NS
LM vs NLM:
HDL: 45 (39-55.8) vs 48 (40-57)b
LDL: 117.5 (98-143) vs 127 (104-151.8)d
TC: 190 (167.5-214) vs 198 (173-227)c
TG: 88 (62-141) vs 91 (66-140.5), NS
LM vs NLM:
CAC = 0: 105 (33.88%) vs 259 (41.70%)c
CAC = 1-100: 103 (33.22%) vs 198 (31.88%), NS
CAC >100: 102 (32.90%) vs 164 (26.41%)c
LM vs NLM: 25.8% vs 16.5%d
Chang et al9 (2009) NFL vs DHS:
SBP: 127.6 ± 16.7 vs 135.6 ± 17.0d
DBP: 77.3 ± 11.2 vs 82.5 ± 10.4d
NFL vs ACLS:
SBP: 129.2 ± 17.0 vs 129 ± 16, NS
DBP: 77.5 ± 11.1 vs 85.0 ± 9.8d
NFL vs DHS:
HDL: 50.8 ± 16.8 vs 43.7 ± 10.9d
LDL: 128.5 ± 36.0 vs 107.7 ± 37.5d
TC: 197.8 ± 42.1 vs 176.8 ± 40.1d
TG: 81 (61-115) vs 111 (74-160)d
NFL vs ACLS:
HDL: 49.4 ± 17.0 vs 46.4 ± 11.5, NS
LDL: 126.0 ± 36.2 vs 124.7 ± 37.2, NS
TC: 192.9 ± 41.9 vs 204.0 ± 41.6d
TG: 83.5 (61-122) vs 127.5 (92-177)d
NFL vs DHS: 46.0% vs 48.3%, NS
No statistically significant difference across CAC values for all groups
NFL vs DHS: significantly lower percentage of retired players with CMS compared with controlsc
NFL vs ACLS: 39.5% vs 23.0%d
Hurst et al30 (2010) NFL vs Mayo:
HT: 38 (19%) vs 6 (7%)
SBP: 128.7 ± 16.4 vs 123.7 ± 13.8b
DBP: 78.7 ± 10.9 vs 78.4 ± 8.2, NS
LM vs NLM:
HT: 12 (20%) vs 9 (6%)c
SBP: 128.8 ± 16.9 vs 128.6 ± 16.2, NS
DBP: 79.2 ± 13.1 vs 78.6 ± 9.9, NS
NFL vs Mayo:
HDL: 40.9 ± 16.5 vs 50.1 ± 13.5, NS
LDL: 131.3 ± 25.6 vs 126.4 ± 35.5, NS
TC: 198.8 ± 40.8 vs 207.2 ± 40.1, NS
TG: 102.6 ± 64.6 vs 162.2 ± 128.3d
LM vs NLM:
HDL: 45.4 ± 18.4 vs 50.5 ± 15.6c
LDL: 127.5 ± 30.1 vs 132.8 ± 37.7, NS
TC: 197.7 ± 37.0 vs 199.2 ± 42.5, NS
TG: 120.5 ± 64.4 vs 95.1 ± 63.4b
NFL vs Mayo: CAP: 67 (33%) vs 36 (29%), NS
LM vs NLM: CAP: 16 (27%) vs 51 (36%), NS
LM vs NLM: 27 (46%) vs 32 (23%)d
Hyman et al31 (2012) HT: 55 (42.6%)
Albuquerque et al1 (2010) NFL vs control:
HT: 37.8% vs 21.4%d
SBP: 133.5 ± 1.1 vs 126.5 ± 0.5d
DBP: 80.0 ± 0.7 vs 72.7 ± 0.3d
NFL vs control:
HDL: 44 ± 0.8 vs 47 ± 0.3d
LDL: 121.4 ± 2.3 vs 117.0 ± 1.3, NS
TC: 183.4 ± 4.1 vs 195.3 ± 1.5, NS
TG: 149.8 ± 12.7 vs 168.0 ± 4.7d
Carruthers et al7 (2017) NFL vs DHS:
SBP: 136.1 (17.2) vs 132.7 (17.0)c
NFL vs DHS:
HDL: 55.9 (16.6) vs 48.9 (12.9)d
NFL vs DHS:
CAC (median [95% CI]): 0.5 (0-45.2) vs 1.8 (0-73), NS
<5% risk:
CAC = 0: 23 (60%) vs 120 (64%), NS
CAC = 1-100: 12 (32%) vs 56 (30%)
CAC >100: 3 (8%) vs 11 (6%)
5%-7.5% risk:
CAC = 0: 15 (65%) vs 61 (48%)c
CAC = 1-100: 3 (13%) vs 53 (41%)
CAC >100: 5 (22%) vs 14 (11%)
>7.5% risk:
CAC = 0: 14 (32%) vs 83 (27%)b
CAC = 1-100: 21 (49%) vs 116 (38%)
CAC >100: 8 (19%) vs 104 (34%)
Kelly et al34 (2014) 34 (50%)
Lynch et al39 (2007) NFL vs control:
SBP: 130 ± 19 vs 133 ± 20, NS
DBP: 79 ± 8 vs 82 ± 13, NS
NFL vs control:
HDL (mM): 1.30 ± 0.23 vs 0.95 ± 0.19d
LDL (mM): 3.10 ± 0.48 vs 3.04 ± 0.61, NS
TC (mM): 4.93 ± 0.52 vs 4.75 ± 0.76, NS
TG (mM): 1.17 ± 0.69 vs 1.71 ± 0.67c
Pokharel et al55 (2014) HT: 267 (32%)
SBP: 130 (121-142)
DBP: 80 (74-87)
HDL: 47 (39-56)
LDL: 125 (103-148)
TC: 196 (171-223)
TG: 89 (64-141)
Virani et al69 (2012) HT: 309 (34.7%) HDL: 49 ± 14
LDL: 127 ± 38
TC: 199 ± 41
TG: 89 ± 77
CAP detected in 41% of players
187 (19.7%)
Luyster et al38 (2017) NFL vs CARDIA:
HT: 36 (29.5%) vs 35 (28.7%), NS
SBP: 125.3 ± 13.9 vs 120.4 ± 13.2b
DBP: 80.1 ± 10.3 vs 75.0 ± 11.2d
LM vs NLM:
HT: 9 (26.5%) vs 27 (30.7%), NS
SBP: 124.6 ± 16.9 vs 125.6 ± 12.7, NS
DBP: 81.4 ± 9.7 vs 80.0 ± 9.7, NS
NFL vs CARDIA:
HDL: 49.9 ± 11.5 vs 44.9 ± 12.0d
LDL: 126.5 ± 39.7 vs 110.5 ± 31.7d
TC: 197.9 ± 43.5 vs 183.4 ± 35.9b
TG: 140.3 ± 96.5 vs 140.2 ± 92.4c
LM vs NLM:
HDL: 47.9 ± 11.9 vs 50.8 ± 11.3, NS
LDL: 135.0 ± 48.7 vs 122.9 ± 34.9, NS
TC: 198.1 ± 55.8 vs 197.9 ± 37.6, NS
TG: 105.3 ± 75.1 vs 120.5 ± 104.3, NS
NFL vs CARDIA:
CAC presence: 37 (30.3%) vs 37 (30.3%), NS
CAC distribution: NS
CAC = 0: 87 (71.3%) vs 87 (71.3%)
CAC = 1-99.99: 29 (23.8%) vs 28 (23%)
CAC ≥100: 6 (4.9%) vs 7 (5.7%)
LM vs NLM:
CAC presence:
8 (23.5%) vs 29 (33.0%), NS

aData are reported as mean ± SD, median (interquartile range), or n (%). ACLS, Aerobics Center Longitudinal Study; BMI, body mass index; CAC, coronary artery calcium; CAP, carotid artery plaque; CARDIA, Coronary Artery Risk Development in Young Adults; CMS, cardiometabolic syndrome; DBP, diastolic blood pressure; DHS, Dallas Heart Study; HDL, high-density lipoprotein; HT, hypertension; LDL, low-density lipoprotein; LM, linemen; Mayo, Mayo Clinic; NFL, National Football League; NLM, nonlinemen; NS, not significant; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.

bP < .01.

cP < .05.

dP < .001.

Lipid Profiles

Eleven studies analyzed measures of lipid profiles.†† A greater prevalence of hyperlipidemia was reported for retired athletes compared with controls and population norms.9,30 The mean total cholesterol for retired athletes was 194.3 mg/dL. Mixed findings were reported for mean total cholesterol for retired athletes compared with control groups; 3 studies reported lower values1,9,30 and 3 reported higher values (Table 3).9,38,39 Most studies examining retired football athletes found higher HDL values compared with controls.1,7,9,30,38,39 The mean LDL for retired football and soccer players was 123.9 mg/dL and 134 mg/dL, respectively, both above recommended levels.1,4,9,21,30,38,39,55,69 All studies reported higher LDL values for retired athletes compared with controls.1,9,30,38,39 Five of 6 studies reported lower triglyceride values in retired athletes.1,9,30,39,52 One of 3 studies investigating the total cholesterol/HDL ratio reported lower values in retired athletes compared with controls.30,39,52

A subgroup analysis based on prior playing position for football showed that retired linemen had higher total cholesterol values in 3 studies4,30,44 and equal values in 1 study.38 Four studies found higher HDL values in retired linemen compared with nonlinemen.4,30,38,44 Conflicting findings for LDL were reported; 2 reported higher values for nonlinemen,4,30 and 1 showed higher values for linemen (Table 3).38 Inconsistencies were found for triglyceride levels; 2 studies reported higher levels for linemen,30,44 and 2 reported higher levels for nonlinemen.4,38

Glucose

The prevalence of diabetes was reported to be between 7% and 8%.1,4,9,31,44,55,69 Conflicting reports on fasting glucose were reported for retired football players; 3 studies found lower values for retired football players, and 2 found higher levels compared with comparators.1,9,30,38,39 Higher glucose values were reported for former linemen compared with nonlinemen.4,30,38,44

Biomarkers

Four studies measured high-sensitivity C-reactive protein (hs-CRP).4,9,55,69 Chang et al9 reported conflicting findings: lower values in retired athletes compared with the DHS cohort but higher values compared with the ACLS cohort. Two studies found no association between hs-CRP levels and CAP or subclinical atherosclerosis.4,69 hs-CRP was found to be significantly higher in retired National Football League (NFL) players with pre-existing CMS.69

Cardiometabolic Syndrome

Six studies reported on the prevalence of CMS in retired football players.4,9,30,34,44,55 A substantial variance was found, ranging from 19.7% to 50%. Compared with the DHS cohort, a significantly lower incidence of CMS was reported; however, compared with the ACLS cohort and controls, a higher prevalence was reported for retired football players.4,9 Retired linemen had almost double the prevalence of CMS compared with nonlinemen (Table 3).4,30,44 Three of the component criteria, BMI ≥30 kg/m2, reduced HDL cholesterol, and raised fasting glucose, were significantly greater in retired linemen compared with nonlinemen.44

CAC/CAP

Three studies found a similar prevalence and severity of CAC between retired athletes and controls.7,9,38 When controlled for ethnicity, no difference in CAC between retired players and the DHS cohort was reported (white: 67.2% vs 57.4%, respectively; African American: 31.5% vs 42.1%, respectively).9 Conflicting findings were reported for the subgroup analysis of football players. Two studies reported a greater prevalence of CAC/CAP for nonlinemen.30,38 However, Miller et al44 reported that retired linemen were less likely to have an absence of CAC, a similar likelihood of mild CAC, and a greater likelihood of moderate to severe CAC compared with nonlinemen (Table 3). Furthermore, after adjusting for demographic and metabolic covariates, the lineman playing position remained independently associated with mild (odds ratio, 1.41 [95% CI, 1.05-2.2]) and moderate to severe (odds ratio, 1.67 [95% CI, 1.05-2.2]) subclinical atherosclerosis.4

Sleep-Disordered Breathing

A limited number of studies analyzed SDB. A self-reported presence of obstructive sleep apnea in retired football players was reported between 41% and 53%.1,31 One study reported that retired football players had double the prevalence of high-risk sleep apnea compared with the CARDIA cohort.38 Retired soccer players reported fewer days of snoring per week than controls.52

Smoking

Retired athletes were reported to have a lower prevalence of smoking (past or present) in all studies.1,7,9,30,38,44,52 Conflicting findings were identified based on playing position in football. Two studies reported a lower prevalence of smoking history in linemen compared with nonlinemen,38,44 whereas 1 study reported a greater prevalence in linemen.30

Meta-analysis

A meta-analysis using random effects and a sensitivity analysis indicated that the overall effect of prior engagement in football had a positive effect on fasting glucose levels, finding a mean difference of –4.66 (95% CI, –7.71 to –1.62; I2 = 55%) when compared with controls (Figure 2). Prior engagement in football had a negative effect on systolic BP, with a mean difference of 3.07 (95% CI, 0.78-5.36; I2 = 44%) in favor of controls (Figure 3). A wide confidence interval was identified for triglycerides of athletes; a mean difference of –19.07 (95% CI, –34.96 to –3.19; I2 = 59%) in favor of retired athletes was found for triglycerides (Figure 4). Retired players had a higher mean LDL value compared with control groups, with a mean difference of 5.00 (95% CI, 1.54-8.47; I2 = 42%) (Figure 5).

Figure 2.

Figure 2.

Forest plot of systolic blood pressure. IV, instrumental variable.

Figure 3.

Figure 3.

Forest plot of glucose. IV, instrumental variable.

Figure 4.

Figure 4.

Forest plot of triglyceride. IV, instrumental variable.

Figure 5.

Figure 5.

Forest plot of low-density lipoprotein (LDL). IV, instrumental variable.

Risk of Bias

Studies were critically appraised using the AXIS tool (Table 1).14 Overall, studies were of moderate quality, with common issues identified in several domains. Where an “unsure” response was assigned, it was most commonly associated with a lack of clarity in reporting. Many studies did not provide justification for the sample size because of their cross-sectional and observational study design. Studies did not address the issue of nonresponders, provide information, or categorize. Samples of convenience were most commonly sought, and it was not addressed how representative these samples were to the true population.

Discussion

This review evaluated 13 studies examining the cardiovascular health profile of retired field-based athletes. The variance in study objectives provides a broad understanding of the cardiovascular health and CVD risk profile of retired contact-sport athletes and how this compares with the general population.

The synthesis of the studies suggests that retired athletes with an elevated BMI have a similar risk for future adverse cardiovascular events to obese nonathletes from the general population. The Framingham study in 2008 indicated that men and women who are obese have a lifetime risk of CVD of 66.8% and 46.7%, respectively.18 Obesity as measured by BMI was common among retired football players and was found to be more prevalent in 5 of 6 studies (83%) compared with comparators.1,7,9,30,38 There is an argument that because BMI does not consider the increased muscle mass in current athletes, as a measure of body composition, BMI may overestimate the prevalence of obesity in current athletes. Despite a 3-fold greater engagement in physical activity during young adulthood (20-34 years), after the age of 65 years, former athletes (66 ± 6 years) and sedentary individuals (67 ± 5 years) have similar levels of physical activity.39 The errors associated with using BMI during an active athletic career are most likely not as significant during retirement; therefore, using BMI as a measure of obesity during retirement is more appropriate, as epidemiological research has consistently reported an increased risk of cardiovascular death with increased BMI.13,35,51,57

Retired linemen were found to have elevated measures of body composition compared with nonlinemen in all but 1 study.4,30,38,44 Luyster et al38 suggested that at an average of 25 years after retirement, nonlinemen have an equal probability of becoming obese to that of linemen. Similarly, Miller et al44 reported that 50% of retired nonlinemen had a BMI ≥30 kg/m2. The mean age of retired NFL players was 57.1 years, falling in line with the estimated 37.7% prevalence of obesity (BMI ≥30 kg/m2) in male patients between the ages of 40 and 59 years from the general population.19 Despite known limitations, BMI remains the most widely used measure of obesity, with 92% (12/13) of studies in this review applying it. It is postulated that waist circumference and waist-to-hip ratio are more accurate indicators of obesity and future risk of CVD for athletes than BMI.8,41 Interestingly, when matched for BMI, both Luyster et al38 and Chang et al9 (DHS) reported a lower waist circumference.

This highlights the need for more reliable measures of body composition beyond BMI, waist circumference, and waist-to-hip ratio, such as DXA. DXA provides an in-depth analysis of body composition, identifying lean mass, fat mass, and visceral adipose tissue (VAT). In current field-based athletes, an elevated BMI often reflects greater lean muscle mass.2,20,33,37,46 Findings from this review suggest that the same may not be the case in retired players. This generates speculation that persistent reporting of an elevated BMI found in retired athletes reflects an increase in fat mass compared with the increased lean mass found in current athletes. No study analyzed VAT in this review. Epidemiological research has consistently reported links between VAT and systemic inflammation.16,53,63,76 It remains unclear if an elevated BMI during retirement diminishes the benefits gained from an individual's past elite athleticism.

The cause of the long-term risk of elevated BP and hypertension in retired field-based athletes is unclear. In current football athletes, there is an increased prevalence of hypertension (13.8%) compared with age- and sex-matched controls (5.5%).68 A 1994 study by the NIOSH reported that deaths among linemen were almost exclusively attributable to hypertension and ischemic heart disease.3 According to the AHA, the risk of death from ischemic heart disease and stroke doubles with every 20–mm Hg systolic BP increase or 10–mm Hg diastolic BP increase among people aged 40 to 89 years.72 The mean systolic BP was 130.6 mm Hg in this review, 10 mm Hg above recommended target levels.6,72

Where elevated BP was reported, concomitant increases in body composition were typically reported.1,7,30 When matched for BMI, results on BP are conflicting. Compared with the DHS cohort, retired football players had lower BP9; however, Hurst et al30 and Luyster et al38 reported higher BP. No study controlled for smoking, alcohol intake, or dietary intake; therefore, it was not possible to identify the cause of higher mean BP in retired players. Furthermore, studies comparing retired NFL players based on positions reported similar or increased BP for linemen.4,30,38,44

This finding suggests that body composition in linemen might offset some benefits of exercise on BP. In retired soccer players, the mean BMI was ≤30 kg/m2 (27.3 kg/m2); however, according to the European Society of Hypertension guidelines,15 66% had BP exceeding the upper range of grade 1 hypertension. This corresponds to statistics from age- and sex-matched individuals from the general population.73 While nonlinemen overall had a statistically similar BMI to linemen (29.8 vs 30.5 kg/m2, respectively) but a greater percentage of African American athletes (47.7% vs 26.4%, respectively; P = .03), the incidence of hypertension was higher for nonlinemen (26.5% vs 30.7%, respectively).38 The meta-analysis identified moderate statistical heterogeneity (I2 = 44%) (Figure 3). A possible cause for the high level of heterogeneity in these studies is the significant difference in smoking history and BMI between retired players and controls, along with measures that were not controlled for.

An increased prevalence of hyperlipidemia and fasting glucose in retired linemen was reported in 2 studies.9,30 Results were conflicting for LDL and HDL concentrations.1,7,9,30,38,39,52 Higher levels of HDL in retired athletes coincided with higher levels of total cholesterol.7,9,38,39 This may be attributed to their physically active and high caloric diet past. Where lower levels of HDL were reported in retired players, elevated measures of body composition were reported.1,30 This suggests that size matters, and early cardiovascular risk factor screening and maintenance of physical activity levels in early retirement are needed.1,9,30,44 Multiple studies reported that hyperlipidemia is associated with coronary atherosclerosis, CAP, and CMS.9,39,44,69 All studies reported that retired players had a higher LDL concentration compared with controls; this may be caused by a high caloric diet during their career or the change in body composition that occurs during retirement.1,9,30,38,39 Increasing body fat percentage coincides with a decrease in physical activity levels, similar to that of obese sedentary controls after the age of 65 years.39

A lower prevalence of diabetes was reported for retired athletes, despite the indication of a 3-fold higher prevalence of impaired fasting glucose.1,9,38 When stratified by ethnicity, African American athletes had a significantly greater prevalence of impaired fasting glucose, whereas white athletes failed to reach significance.9 The high percentage of African American athletes in retired football player groups provides a possible understanding for the difference in impaired fasting glucose levels between retired athletes and controls, warranting further investigations. All studies reported linemen to have a higher impaired fasting glucose concentration than nonlinemen.4,30,38,44 Although the cardiovascular risks affiliated with CMS and increased body size are inevitable during early retirement, engagement in physical activity during a professional sporting career may slow the progression from impaired fasting glucose to diabetes mellitus and decreases the risk of developing an atherogenic lipoprotein profile. An initial meta-analysis of glucose identified a high level of heterogeneity (I2 = 86%). The removal of the study by Albuquerque et al1 reduced heterogeneity to a moderate level (I2 = 55%), indicating a significantly lower level of fasting glucose for retired players. However, insufficient methodological information prevents an investigation into possible causes.

CMS, an established risk factor for CVD,54 was shown to be highly prevalent among retired athletes.34,44,52,55 The lineman position was associated with, and in some studies doubled, its prevalence compared with nonlinemen and comparators.4,30,44 Three components of CMS, BMI ≥30 kg/m2, increased fasting glucose, and decreased HDL, were significantly more prevalent in linemen.44 This is further supported by an association between CMS and increased weight gain.9,52 Athletes playing in the lineman position are exposed to an increased likelihood of developing CMS after retirement. However, the classification of CMS may overestimate the cardiovascular risk in larger retired players, as previously discussed; BMI is a poor indicator of body composition in this cohort.50 The mean age of retired athletes in this review was 57.1 years; therefore, it is debatable how long into retirement BMI remains an inapplicable measure because of prior elite athleticism. Identification of the high prevalence in retired athletes is important, as many of the components of CMS are reversible with lifestyle changes, physical activity, and diet.

As measures of subclinical atherosclerosis, CAP and CAC are strongly and independently associated with adverse cardiovascular events.5,74 Despite high levels of physical activity throughout their athletic career, after retirement, former athletes have a prevalence and distribution of subclinical atherosclerosis similar to those of the general population matched for age, sex, and BMI.7,9,30,38,39 The presence of CAP and CAC is a sign of advanced atherosclerosis and has significant diagnostic implications. The prevalence of CAC was consistently reported in at least one-third of retired players.9,30,38,55 CAC <100 was present in 76% of retired players, posing a concern9; the risk of an adverse cardiovascular event increases several-fold higher with CAC ≥100.10 Retired linemen were more likely to have a moderate to severe presence of CAC and less likely to have an absence of CAC compared with nonlinemen.4,30 Possible explanations for a higher risk of moderate to severe CAC include an increased prevalence of obesity, hypertension, CMS, and SDB. However, it is difficult to rule out factors beyond those measured in these studies, including but not limited to steroid use, race, and socioeconomic status. These findings suggest that former athletes have not benefited from their athletic past, despite the well-documented cardioprotective benefits associated with prolonged engagement in exercise.47

Limited data suggest that obstructive sleep apnea may be more prevalent after retirement, possibly explained by the previously discussed elevated BMI and increased prevalence of obesity.1,31,38 Retired soccer players’ lower mean BMI of 27.3 kg/m2 was associated with a lower incidence of obstructive sleep apnea compared with controls and retired football players.52 However, Luyster et al38 reported that despite similar levels of obesity, the sleep apnea risk was twice that for retired football players compared with controls, giving plausibility to other possible causes for an increased prevalence, beyond BMI.

This review is limited by several factors. First, studies included were cross-sectional, observational, or prospective; therefore, inferences on temporality and causality cannot be made from the observed findings. Results should be viewed as hypothesis generating only. Second, 12 of the 13 studies included were based on retired football players; therefore, caution is needed when interpreting conclusions to all retired field-based athletes. It is worth noting that all studies included male athletes who were retired from professional sports; therefore, the applicability to amateur and female athletes is limited. A high proportion of retired athletes, primarily football players, were African American, limiting the generalizability of results. Caution is needed when interpreting findings, given the disproportionate percentage of African American retired football players who have a higher predisposition for increased BP and hypertension.40 Because of the limited amount of research in this area, a control group was not implemented into our inclusion criteria to widen the number of studies that could be analyzed. All studies recruited participants from open health screening events, allowing for self-selection bias; however, this applies to all participants: linemen, nonlinemen, and retired soccer players. There are possible unknown causes for findings; for example, the previous use of anabolic androgenic steroids could have multiple deleterious effects on the cardiovascular system, altering lipid profiles, promoting atherosclerosis, enhancing thrombogenesis, and altering body composition.

Other possible confounding factors include years in retirement, diet, alcohol use, socioeconomic status, education, genetics, and medication use. The use of self-reported screening tools for obstructive sleep apnea without objective assessments precludes the confirmation that participants who scored in the high-risk range had obstructive sleep apnea. Therefore, the proportion of high-risk participants may be overestimated or underestimated. Finally, it was difficult to acquire a similar comparator population. The general population and cohorts from larger studies were used; however, not all studies matched controls for ethnicity, race, and body composition.

Conclusion

There is inconsistency in the screening and reporting of CVD risk factors in retired field-based athletes. Most studies have focused on retired football players, with only 1 study examining retired soccer players. There is a need for research in field-based athletes from other sports, particularly in sports that emphasize a greater body mass. There is also a need for research on cardiovascular risks in female athletes from similar sports. This current synthesis of studies has demonstrated that heavier retired field-based athletes are at a risk of elevated BP, hypertension, increased LDL, SDB, CMS, and the development of CAP and CAC. It can be inferred that this risk is comparable with obese nonathlete counterparts. BMI might not be an appropriate measurement of cardiovascular health in retired field-based athletes, and other measures of body composition may be more valuable. Further research is needed, focusing on retired athletes of other field-based sports such as rugby, hockey, and soccer, as well as retired female athletes, to gain clear insight into the cardiovascular health of all field-based sports.

Acknowledgment

The authors acknowledge David Mockler, medical librarian, for his support.

APPENDIX

TABLE A1.

Study Detailsa

Author (Year) Study Design Primary Aims Setting Participants Variables Risk Factor Prevalence
Miller et al44 (2008) Cross-sectional prevalence To assess the prevalence of CMS in athletes; to assess the prevalence of CMS based on playing position Living Heart Foundation health screening, 2004-2006 NFL; n = 510; male; mean age: 53.8 y; sex-matched controls from NHANES; LM vs NLM BMI, BF%, SBP, DBP, HT, TC, TG, HDL, LDL, fasting glucose, CMS, smoking, DM CMS was more prevalent in LM than NLM (59.8% vs 30.1%, respectively; P = .001); elevated BMI and impaired fasting glucose and reduced HDL were more prevalent in LM than NLM
Panayiotoglou et al52 (2017) Cross-sectional case-control To determine the risk and prevalence of CMS in retired professional soccer players Greece Soccer; n = 12; male; mean age: 46.7 y; age-, sex-, and BMI-matched nonathletic controls BMI, BF%, WHR, blood pressure, snoring, smoking, TG, TC/HDL, non-HDL/HDL Prevalence of CMS was not different between groups; retired players with CMS gained significantly more weight since retirement
Basra et al4 (2014) Cross-sectional To evaluate the presence and severity of subclinical atherosclerosis; to evaluate whether the lineman position is independently associated with an increased risk of subclinical atherosclerosis Living Heart Foundation health screening, 2007-2009 NFL; n = 931; male; mean age: 54 y; no comparators; LM vs NLM BMI, WC, SBP, hs-CRP, TC, HDL-C, LDL-C, TG, fasting glucose, CMS, HT, DM, smoking, CAC LM were less likely to have absence of CAC (33.8% vs 41.7%, respectively; P = .02) and had greater likelihood of moderate to severe CAC (32.9% vs 26.4%, respectively; P = .04)
Chang et al9 (2009) Cross-sectional To assess the prevalence of CAC in retired NFL players compared with physically active controls; to evaluate retired players’ true risk of an adverse cardiovascular event Living Heart Foundation health screening, 2007 NFL; n = 201; male; mean age: 51.2 y; age-, sex-, BMI-, and ethnicity-matched participants from DHS and ACLS BMI, WC, WHR, SBP, DBP, fasting insulin, fasting glucose, TC, HDL, LDL, TG, HbA1C, CMS, DM, smoking, CAC, HT, hs-CRP There was no significant difference in CAC prevalence (46.0% vs 48.3%, respectively; P = .69) or distribution (P = .11) between retired players and controls
Hurst et al30 (2010) Cross-sectional To evaluate subclinical atherosclerosis in retired NFL players; to assess the cardiovascular risk in professional football players Living Heart Foundation health screening, 2006-2007 NFL; n = 201; male; mean age: 50.8 y; age-, sex-, BMI-, and smoking prevalence–matched controls from Mayo (2006-2007); LM vs NLM BMI, smoking, HT, SBP, DBP, hyperlipidemia, TC, HDL, LDL, TG, TC/HDL, fasting glucose, CAP, CMS Prevalence of CAP in players was not significantly different to BMI-matched controls (33.3% vs 29.3%, respectively; P = .45); CMS was more prevalent in LM than NLM (45.8% vs 22.5%, respectively; P = .001)
Hyman et al31 (2012) Observational To validate the accuracy of BMI when measuring obesity in the retired NFL population; to investigate the correlation between obesity and several comorbidities in this population Internal medicine practice, 5/2010-6/2011 NFL; n = 129; male; mean age: 42.2 y; no comparators; LM vs NLM BMI, HT, obstructive SA, left ventricular hypertrophy, DM BMI has poor specificity (0.36) in classifying obesity in retired football players; BMI/obesity was correlated with LM (P < .0001) and obstructed SA (P = .0005)
Albuquerque et al1 (2010) Cross-sectional To assess the prevalence of SDB and HT; to compare the risk of CVD between retired NFL players and controls Living Heart Foundation health screening, 2006 NFL; n = 257; male; mean age: 53.9 y; age-, sex-, and BMI-matched cohort from NHANES BMI, SBP, DBP, HT, obesity, TC, TG, HDL, LDL, fasting glucose, DM, smoking, apnea-hypopnea, SDB SDB was present in 52.3% of retired players; prevalence of HT and obesity (P < .001) was higher in retired players; LM were more likely to have SDB (61.3% vs 46.6%, respectively; P = .02) and obesity (83.5% vs 52.5%, respectively; P < .001) compared with NLM; retired players had lower TC, TG, HDL, and impaired fasting glucose than controls
Carruthers et al7 (2017) Cross-sectional To assess the 10-y risk of atherosclerotic CVD in elite former athletes Not specified NFL; n = 104; male; mean age: 53.8 y; age- and sex-matched participants from DHS BMI, SBP, non-HDL, HDL, median CAC, median atherosclerotic CVD risk, smoking Compared with DHS, retired NFL players had no significant differences in odds of having CAC = 0 among participants with a high atherosclerotic CVD risk (OR, 1.37 [95% CI, 0.36-5.17]) or in odds of having high CAC (>100) among participants with a low atherosclerotic CVD risk (OR, 1.28 [95% CI, 0.64-2.54])
Kelly et al34 (2014) Prospective To determine the rate of metabolic dysfunction in retired NFL players Providence St John’s Health Center; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center NFL; n = 74; male; mean age: 47.3 y; no comparators; non–hormone deficient vs hormone deficient BMI, CMS, IGF-1 CMS was present in 50% of retired players; BMI increased significantly (P < .001) for players during retirement
Lynch et al39 (2007) Cross-sectional To determine if playing professional football as a young adult is associated with a more favorable cardiovascular risk profile and greater bone density and lean mass compared with their healthy peers University of Maryland NFL; n = 16; male; mean age: 66 y; sex-, BMI-, race-, and current physical activity–matched never-athletic comparators BMI, WC, WHR, BF%, TC, LDL, HDL, TG, fasting insulin, fasting glucose, blood pressure Retired players had a more favorable body composition and cardiovascular risk profile than controls: 37% higher HDL, 4-fold higher HDL2, 25% lower TC/HDL, and 31% lower TG (P < .05 to P < .001)
Pokharel et al55 (2014) Cross-sectional To examine the association of NC with other markers of adiposity and components of CMS; to examine whether NC is independently associated with subclinical atherosclerosis as assessed by CAC and CAP NFL Player Care Foundation; Living Heart Foundation; Boone Heart Institute NFL; n = 845; male; mean age: 54 y; no comparators HT, DM, SBP, DBP, BMI, NC, WC, fasting blood glucose, hs-CRP, TC, LDL, HDL, TG, CMS, CAC/CAP 21% had CMS, 62% had CAC, and 56% had CAP present; NC was not associated with CAC or CAP after adjusting for age, race, and cardiometabolic risk factors
Virani et al69 (2012) Cross-sectional To assess whether LDL-P concentration and hs-CRP can identify subclinical atherosclerosis better than traditional cholesterol parameters; to assess if hs-CRP is associated with CAP in retired NFL players Living Heart Foundation and Boone Heart Institute, 9/2007-11/2009 NFL; n = 948; male; mean age: 53.5 y; no comparators; CMS vs no CMS HT, DM,CMS, WC, TC, LDL, non-HDL, TG, LDL-P, HDL, hs-CRP CAP was common in retired players (41%) and strongly associated with LDL-P (OR, 3.71 [95% CI, 1.16-11.84]); 19.7% of retired players had CMS; hs-CRP was not associated with CAP (OR, 1.13 [95% CI, 0.71-1.79])
Luyster et al38 (2017) Cross-sectional To compare the SA risk in young- to middle-aged retired NFL players with a community cohort; to compare the SA risk based on playing position NFL Player Care Foundation Cardiovascular Health Screening Program, 2007-2012 NFL; n = 122; male; mean age: 45.3 y; age-, sex-, race-, and BMI-matched cohort from CARDIA Smoking, WC, BMI, obesity, SBP, DBP, TC, HDL, LDL, TG, DM, fasting glucose, sleep duration, SA risk, CAC Retired players had greater prevalence of high SA risk (27.0% vs 11.5%, respectively; P = .002) but similar prevalence of CAC compared with matched controls (30% vs 30%, respectively; P = 1)

aACLS, Aerobics Center Longitudinal Study; BF%, body fat percentage; BMI, body mass index; CAC, coronary artery calcium; CAP, carotid artery plaque; CARDIA, Coronary Artery Risk Development in Young Adults; CMS, cardiometabolic syndrome; CVD, cardiovascular disease; DBP, diastolic blood pressure; DHS, Dallas Heart Study; DM, diabetes mellitus; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; HT, hypertension; IGF-1, insulin-like growth factor 1; LDL, low-density lipoprotein; LDL-C, low-density lipoprotein cholesterol; LDL-P, low-density lipoprotein particle number; LM, linemen; Mayo, Mayo Clinic; NC, neck circumference; NFL, National Football League; NHANES, National Health and Nutrition Examination Survey; NLM, nonlinemen; OR, odds ratio; SA, sleep apnea; SBP, systolic blood pressure; SDB, sleep-disordered breathing; TC, total cholesterol; TG, triglyceride; WC, waist circumference; WHR, waist-to-hip ratio.

One or more of the authors has declared the following potential conflict of interest or source of funding: This study is part of a wider PhD research by the primary investigator (C.M.). Funding for this research was provided through a research studentship at Trinity College Dublin. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.

||

References 1, 4, 7, 9, 30, 31, 34, 38, 39, 44, 52, 55, 69.

References 1, 4, 7, 9, 30, 31, 34, 38, 39, 44, 55, 69.

#

References 1, 4, 7, 9, 30, 31, 34, 38, 39, 44, 55, 69.

**

References 1, 4, 7, 9, 30, 34, 38, 39, 44, 52, 55.

††

References 1, 4, 7, 9, 30, 38, 39, 44, 52, 55, 69.

References

  • 1. Albuquerque FN, Kuniyoshi FH, Calvin AD. et al. Sleep-disordered breathing, hypertension, and obesity in retired National Football League players. J Am Coll Cardiol. 2010;56(17):1432–1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Barlow MJ, Oldroyd B, Smith D. et al. Precision error in dual energy X-ray absorptiometery body composition measurements in elite male rugby players. J Clin Densitom. 2015;18(4):546–550. [DOI] [PubMed] [Google Scholar]
  • 3. Baron S, Rinsky R. NIOSH Mortality Study of NFL Football Players: 1959-1988. Washington, DC: National Institute for Occupational Safety and Health; 1994. [Google Scholar]
  • 4. Basra SS, Pokharel Y, Hira RS. et al. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014;114(12):1836–1840. [DOI] [PubMed] [Google Scholar]
  • 5. Belcaro G, Nicolaides AN, Ramaswami G. et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study 1). Atherosclerosis. 2001;156(2):379–387. [DOI] [PubMed] [Google Scholar]
  • 6. Brignole M. “Ten commandments” of ESC syncope guidelines 2018: the new European Society of Cardiology (ESC) clinical practice guidelines for the diagnosis and management of syncope were launched 19 March 2018 at EHRA 2018 in Barcelona. Eur Heart J. 2018;39(21):1870–1871. [DOI] [PubMed] [Google Scholar]
  • 7. Carruthers D, Joshi P, Maroules C. et al. Pooled cohort equation and coronary artery calcium in retired National Football League athletes. J Am Coll Cardiol. 2017;69(suppl 11):1449. [Google Scholar]
  • 8. Caselli S, Di Paolo FM, Pisicchio C, Pandian NG, Pelliccia A. Patterns of left ventricular diastolic function in Olympic athletes. J Am Soc Echocardiogr. 2015;28(2):236–244. [DOI] [PubMed] [Google Scholar]
  • 9. Chang AY, FitzGerald SJ, Cannaday J. et al. Cardiovascular risk factors and coronary atherosclerosis in retired National Football League players. Am J Cardiol. 2009;104(6):805–811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Church TS, Levine BD, McGuire DK. et al. Coronary artery calcium score, risk factors, and incident coronary heart disease events. Atherosclerosis. 2007;190(1):224–231. [DOI] [PubMed] [Google Scholar]
  • 11. Croft LB, Belanger A, Miller MA, Roberts A, Goldman ME. Comparison of National Football League linemen versus nonlinemen of left ventricular mass and left atrial size. Am J Cardiol. 2008;102(3):343–347. [DOI] [PubMed] [Google Scholar]
  • 12. De Backer G, Ambrosioni E, Borch-Johnsen K. et al. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Arch Mal Coeur Vaiss. 2004;97(10):1019–1030. [PubMed] [Google Scholar]
  • 13. Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med. 1993;153(9):1093–1103. [DOI] [PubMed] [Google Scholar]
  • 14. Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6(12):e011458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. European Society of Hypertension. European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011–1053. [DOI] [PubMed] [Google Scholar]
  • 16. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010–1013. [DOI] [PubMed] [Google Scholar]
  • 17. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–1778. [DOI] [PubMed] [Google Scholar]
  • 18. Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D’Agostino RB. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham Heart Study. Diabetes Care. 2008;31(8):1582–1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Fryar CD, Gu Q, Ogden CL, Flegal KM. Anthropometric Reference Data for Children and Adults: United States, 2011-2014 Atlanta, Georgia: Centers for Disease Control and Prevention; 2016. [PubMed] [Google Scholar]
  • 20. Georgeson EC, Weeks BK, McLellan C, Beck BR. Seasonal change in bone, muscle and fat in professional rugby league players and its relationship to injury: a cohort study. BMJ Open. 2012;2:e001400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Gibbons GH, Shurin SB, Mensah GA, Lauer MS. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2013;62(15):1396–1398. [DOI] [PubMed] [Google Scholar]
  • 22. Greenland P, Alpert JS, Beller GA. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56(25):e50–e103. [DOI] [PubMed] [Google Scholar]
  • 23. Grundy SM, Cleeman JI, Daniels SR. et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol. 2005;4(4):198–203. [DOI] [PubMed] [Google Scholar]
  • 24. Hargrove T. Supersized in the NFL: many ex-players dying young. Scripps Howard News Service Online. http://nflretirees.blogspot.com/2006/02/supersized-in-nfl-many-ex-players.html. Published 2007. Accessed February 29, 2018.
  • 25. Haskell WL, Lee I-M, Pate RR. et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1081. [DOI] [PubMed] [Google Scholar]
  • 26. Helzberg JH, Waeckerle JF, Camilo J. et al. Comparison of cardiovascular and metabolic risk factors in professional baseball players versus professional football players. Am J Cardiol. 2010;106(5):664–667. [DOI] [PubMed] [Google Scholar]
  • 27. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. [DOI] [PubMed] [Google Scholar]
  • 28. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004;351(26):2694–2703. [DOI] [PubMed] [Google Scholar]
  • 29. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–977. [DOI] [PubMed] [Google Scholar]
  • 30. Hurst RT, Burke RF, Wissner E. et al. Incidence of subclinical atherosclerosis as a marker of cardiovascular risk in retired professional football players. Am J Cardiol. 2010;105(8):1107–1111. [DOI] [PubMed] [Google Scholar]
  • 31. Hyman MH, Dang DL, Liu Y. Differences in obesity measures and selected comorbidities in former National Football League professional athletes. J Occup Environ Med. 2012;54(7):816–819. [DOI] [PubMed] [Google Scholar]
  • 32. Jensen MD, Ryan DH, Apovian CM. et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25 pt B):2985–3023. [DOI] [PubMed] [Google Scholar]
  • 33. Jones B, Till K, Barlow M, Lees M, O’Hara JP, Hind K. Anthropometric and three-compartment body composition differences between Super League and Championship Rugby League players: considerations for the 2015 season and beyond. PLoS One. 2015;10(7):e0133188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Kelly DF, Chaloner C, Evans D. et al. Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma. 2014;31(13):1161–1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Kujala UM, Kaprio J, Taimela S, Sarna S. Prevalence of diabetes, hypertension, and ischemic heart disease in former elite athletes. Metabolism. 1994;43(10):1255–1260. [DOI] [PubMed] [Google Scholar]
  • 36. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr. 1999;69(3):373–380. [DOI] [PubMed] [Google Scholar]
  • 37. Lees MJ, Oldroyd B, Jones B. et al. Three-compartment body composition changes in professional rugby union players over one competitive season: a team and individualized approach. J Clin Densitom. 2017;20(1):50–57. [DOI] [PubMed] [Google Scholar]
  • 38. Luyster FS, Dunn RE, Lauderdale DS. et al. Sleep-apnea risk and subclinical atherosclerosis in early-middle-aged retired National Football League players. Nat Sci Sleep. 2017;9:31–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Lynch NA, Ryan AS, Evans J, Katzel LI, Goldberg AP. Older elite football players have reduced cardiac and osteoporosis risk factors. Med Sci Sports Exerc. 2007;39(7):1124–1130. [DOI] [PubMed] [Google Scholar]
  • 40. Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Pressure. 2013;22(4):193–278. [DOI] [PubMed] [Google Scholar]
  • 41. Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357. [DOI] [PubMed] [Google Scholar]
  • 42. Mathews DK, Fox EL, Tanzi D. Physiological responses during exercise and recovery in a football uniform. J Appl Physiol. 1969;26(5):611–615. [DOI] [PubMed] [Google Scholar]
  • 43. Mathews EM, Wagner DR. Prevalence of overweight and obesity in collegiate American football players, by position. J Am Coll Health. 2008;57(1):33–38. [DOI] [PubMed] [Google Scholar]
  • 44. Miller MA, Croft LB, Belanger AR. et al. Prevalence of metabolic syndrome in retired National Football League players. Am J Cardiol. 2008;101(9):1281–1284. [DOI] [PubMed] [Google Scholar]
  • 45. Moher D, Liberati A, Tetzlaff J, Altman DG; the PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Morehen JC, Routledge HE, Twist C, Morton JP, Close GL. Position specific differences in the anthropometric characteristics of elite European Super League rugby players. Eur J Sport Sci. 2015;15(6):523–529. [DOI] [PubMed] [Google Scholar]
  • 47. Myers J, Prakash M, Froelicher V, Do D, Partington S, Edwin Atwood J. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801. [DOI] [PubMed] [Google Scholar]
  • 48. Nevill AM, Stewart AD, Olds T, Holder R. Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol. 2006;129(1):151–156. [DOI] [PubMed] [Google Scholar]
  • 49. Nevill AM, Winter EM, Ingham S, Watts A, Metsios GS, Stewart AD. Adjusting athletes’ body mass index to better reflect adiposity in epidemiological research. J Sports Sci. 2010;28(9):1009–1016. [DOI] [PubMed] [Google Scholar]
  • 50. Ode JJ, Pivarnik JM, Reeves MJ, Knous JL. Body mass index as a predictor of percent fat in college athletes and nonathletes. Med Sci Sports Exerc. 2007;39(3):403–409. [DOI] [PubMed] [Google Scholar]
  • 51. Paffenbarger RS, Hyde RT, Wing AL, Steinmetz CH. A natural history of athleticism and cardiovascular health. JAMA. 1984;252(4):491–495. [PubMed] [Google Scholar]
  • 52. Panayiotoglou A, Grammatikopoulou MG, Maraki MI. et al. Metabolic syndrome in retired soccer players: a pilot study. Obesity Med. 2017;8:15–22. [Google Scholar]
  • 53. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract. 2005;69(1):29–35. [DOI] [PubMed] [Google Scholar]
  • 54. Perk J, De Backer G, Gohlke H. et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–1701. [DOI] [PubMed] [Google Scholar]
  • 55. Pokharel Y, Macedo FY, Nambi V. et al. Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol. 2014;37(7):402–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Punjabi NM, Caffo BS, Goodwin JL. et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6(8):e1000132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Rabkin SW, Leiter L, Reeder BA, Chen Y, Liu L. Risk factor correlates of body mass index: Canadian Heart Health Surveys Research Group. CMAJ. 1997;157(suppl 1):S26–S31. [PubMed] [Google Scholar]
  • 58. Reiner Ž, Catapano AL, De Backer G. et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769–1818. [DOI] [PubMed] [Google Scholar]
  • 59. Ryden L, Standl E, Bartnik M. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88–136. [DOI] [PubMed] [Google Scholar]
  • 60. Selden MA, Helzberg JH, Waeckerle JF. et al. Cardiometabolic abnormalities in current National Football League players. Am J Cardiol. 2009;103(7):969–971. [DOI] [PubMed] [Google Scholar]
  • 61. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228(3):826–833. [DOI] [PubMed] [Google Scholar]
  • 62. Shea JL, Randell EW, Sun G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring). 2011;19(3):624–630. [DOI] [PubMed] [Google Scholar]
  • 63. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Silva GE, Vana KD, Goodwin JL, Sherrill DL, Quan SF. Identification of patients with sleep disordered breathing: comparing the four-variable screening tool, STOP, STOP-Bang, and Epworth Sleepiness Scales. J Clin Sleep Med. 2011;7(5):467–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Smith SC, Allen J, Blair SN. et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47(10):2130–2139. [DOI] [PubMed] [Google Scholar]
  • 66. Somers VK, White DP, Amin R. et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). J Am Coll Cardiol. 2008;52(8):686–717. [DOI] [PubMed] [Google Scholar]
  • 67. Stein JH, Korcarz CE, Hurst RT. et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–111. [DOI] [PubMed] [Google Scholar]
  • 68. Tucker AM, Vogel RA, Lincoln AE. et al. Prevalence of cardiovascular disease risk factors among National Football League players. JAMA. 2009;301(20):2111–2119. [DOI] [PubMed] [Google Scholar]
  • 69. Virani SS, Pompeii L, Lincoln AE. et al. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012;222(2):551–556. [DOI] [PubMed] [Google Scholar]
  • 70. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499. [DOI] [PubMed] [Google Scholar]
  • 71. Warren JM, Ekelund U, Besson H, Mezzani A, Geladas N, Vanhees L. Assessment of physical activity: a review of methodologies with reference to epidemiological research. A report of the Exercise Physiology Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(2):127–139. [DOI] [PubMed] [Google Scholar]
  • 72. Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. [DOI] [PubMed] [Google Scholar]
  • 73. Wolf-Maier K, Cooper RS, Banegas JR. et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363–2369. [DOI] [PubMed] [Google Scholar]
  • 74. Wyman RA, Mays ME, McBride PE, Stein JH. Ultrasound-detected carotid plaque as a predictor of cardiovascular events. Vasc Med. 2006;11(2):123–130. [DOI] [PubMed] [Google Scholar]
  • 75. Yamamoto JB, Yamamoto BE, Yamamoto PP, Yamamoto LG. Epidemiology of college athlete sizes, 1950s to current. Res Sports Med. 2008;16(2):111–127. [DOI] [PubMed] [Google Scholar]
  • 76. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148(2):209–214. [DOI] [PubMed] [Google Scholar]

Articles from Orthopaedic Journal of Sports Medicine are provided here courtesy of SAGE Publications

RESOURCES